Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | H52 - ABPN Continuing Certification in Academic Careers (Academic Hub)

Sunday 04/14/24
12:30 PM - 01:15 PM MDT Add To Calendar
Colorado Convention Center | Mile High 1A
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Academic)
Jeffrey M. Lyness, MD, Amy R. Brooks-Kayal, MD, FAAN
General Neurology
A panel will discuss recent activities at the ABPN, as well as continuing certification requirements, with an emphasis on how those requirements may be met by neurologists engaged in academic careers. There will designated time for attendee discussion.
No CME available
Professionalism
Intermediate
Audience Participation, Panel Discussion

Program Materials Program Evaluations

Event Timeline
12:30 PM - 01:15 PM MDT Speaker ABPN Continuing Certification in Academic Careers
Jeffrey M. Lyness, MD, Amy R. Brooks-Kayal, MD, FAAN
Faculty Disclosures
Jeffrey M. Lyness, MD Dr. Lyness has received personal compensation for serving as an employee of American Board of Psychiatry & Neurology. Dr. Lyness has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry & Neurology. Dr. Lyness has stock in Apple, Inc.. Dr. Lyness has received publishing royalties from a publication relating to health care.
Amy R. Brooks-Kayal, MD, FAAN Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Brooks-Kayal has stock in Johnson and Johnson. The institution of Dr. Brooks-Kayal has received research support from NINDS.